Psychedelics at the end of life. How they could make our final journey easier
March 18, 2025
Psychedelic-assisted therapies have been used in psychotherapy for some time with some success. A conversation in Morgen:Rapport about the question of what LSD, MDMA, psilocybin and co. can do for people in the last phase of life.
Psychedelics have been used successfully in psychotherapy for some time now. These substances often bring astonishing relief in cases of depression or chronic pain. As initial studies show, they could also be of considerable benefit in the field of palliative care for people at the end of life, for example by alleviating the fear of dying - and giving us a new perspective on our own biography.
Sivan Schipper, Head of Internal Medicine and Palliative Care at Uster Hospital, is researching the potential of psychedelic-assisted therapies at the end of life. We talk to him about the opportunities and risks of such approaches and ask what gaps they could close in palliative care. Jean-Daniel Strub, ethicist and head of the Neumünster Institute at Gesundheitswelt Zollikerberg, will be conducting the interview.
Weitere Beiträge
Podcast
"finally." - the new Morgen:Rapport about good design for fragile times
A podcast episode all about design. But not design for design's sake - but design that creates real added value for patients, people in need of care, relatives and professionals in health and care facilities.
Podcast
With gait analysis for a more precise diagnosis of depression. How our gait shows how we are feeling
The precise observation of human gait not only enables more precise diagnoses and a measurement of the progress of therapy for depression, but also has potential for therapy. A conversation about what the human gait reveals about our innermost being.
Podcast
Planetary Health. How the healthcare sector is on board with climate change
Climate change and health - Healthcare and climate change: the connections are far more diverse than they often seem.